GlassScriptPhysician profile
Kathryn Confer
NPI 1306482864
$924.47
in general payments reported to CMS, 2019-2025
14 companies · $222 in 2025
The $222 reported for 2025 was more than what 83% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $52.87 · 2022: $131 · 2023: $328 · 2024: $191 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $741.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $182.96 | 2023-2024 | Veozah |
| Organon LLC | $166.42 | 2021-2024 | Nexplanon |
| Biogen, INC. | $161.50 | 2025 | Zurzuvae |
| Exeltis, USA INC. | $107.61 | 2022-2025 | Slynd |
| Mayne Pharma Commercial LLC | $62.27 | 2022-2025 | |
| Myovant Sciences INC. | $58.97 | 2022 | |
| Coopersurgical, INC. | $33.90 | 2023 | Paragard T 380a |
| Myriad Women'S Health, INC. | $31.64 | 2023 | Myrisk |
| Bayer Healthcare Pharmaceuticals INC. | $26.63 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $25.22 | 2023 | Myrisk |
| Dexcom, INC. | $21.10 | 2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $17.87 | 2021 | |
| Shield Therapeutics INC | $14.47 | 2024 | |
| Hologic Sales and Service, LLC | $13.91 | 2023 | Acessa Provu System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Confer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.